☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
shuttle pharma
Shuttle Pharma Reports the Completion of Clinical Trial Site Enrollment for the P-II Study of Ropidoxuridine for Glioblastoma
October 29, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.